Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.22.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 17, 2020
Balance (in Shares) at Jun. 17, 2020      
Sale of 4,312,500 Founder Shares $ 431 24,569 25,000
Sale of 4,312,500 Founder Shares (in Shares) 4,312,500      
Net loss (1,000) (1,000)
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Dec. 31, 2020 4,312,500      
Net proceeds from Initial Public Offering allocated to Rights   3,845,970   3,845,970
Excess of cash received over fair value of private placement warrants 4,161,500 4,161,500
Change in fair value of over-allotment option liability     225,000 225,000
Accretion of Common Stock to possible redemption amount (8,032,039) (7,337,675) (15,369,714)
Net loss (595,442) (595,442)
Balance at Dec. 31, 2021 $ 431 $ (7,709,117) $ (7,708,686)
Balance (in Shares) at Dec. 31, 2021 4,312,500